GET THE APP

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Author(s): Priyanshu Jain and Vinay Madhav Pathak

The aim of present work is to develop and validate simple, sensitive and specific spectrophotometric method for the determination of rifapentin, an anti-tubercular drug in pure form and in pharmaceutical formulations. UV-VISIBLE spectrophotometric method, which is based on measurement of absorption at maximum wavelength in 0.1N HCl, was found to be at 478 nm. The developed method was validated with respect to linearity, accuracy (recovery), precision and specificity. The optimum conditions for analysis of the drug were established. The drug obeyed the Beer’s law and showed good correlation. Beer’s law was obeyed in concentration range 5-50 μg/ml having line equation y = 0.004x + 0.024 with correlation coefficient of 0.999. The results of analysis were validated by recovery studies. The method was found to be simple, accurate, precise, economical and robust.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 23677

Der Pharma Chemica received 23677 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry